Financial Data and Key Metrics Changes - Revenue for Q3 was $35 million, a decline of 17.8% compared to the prior year quarter, with same-store revenue down approximately 22% [13] - Cases declined 15.2% to 2,780, with same-store cases down approximately 20% [13] - Average revenue per case was $12,587, a decline of approximately 3% from the prior year quarter [14] - Adjusted EBITDA was $3 million, down from $4.7 million in the prior year quarter, with an adjusted EBITDA margin of 8.7% compared to 11% [15] - Net loss for the quarter was $9.5 million, with an adjusted net loss of $2.4 million, or $0.04 per diluted share [15] Business Line Data and Key Metrics Changes - The introduction of skin tightening services has seen a lift in demand, but many clients require additional procedures for loose skin beyond what skin tightening can address [8][26] - The company is expanding its service offerings to include skin excisions and removals, which are currently in pilot [26] Market Data and Key Metrics Changes - Global GLP-1 prescriptions have grown at approximately 38% annually between 2022 and 2024, with total sales expected to reach $100 billion by 2030 [6] - 63% of GLP-1 patients are seeking aesthetic treatments post-use, indicating a new consumer base for the company [7] Company Strategy and Development Direction - The company is focusing on three key areas: introducing new services to capture the GLP-1 opportunity, enhancing sales and marketing strategies, and maintaining financial discipline [4][12] - The strategy includes adapting marketing spend to align with revenue trends and prioritizing initiatives that drive higher conversion rates [8] Management's Comments on Operating Environment and Future Outlook - Management noted that while Q3 revenue was lower than expected, it reflects timing rather than a change in business trajectory [4] - The company updated its annual outlook, expecting 2025 revenue of approximately $153 million, down from previous guidance of $160 million to $170 million [10][19] Other Important Information - The company announced the appointment of Michael Arthur as the new CFO starting January 2026, succeeding Dennis Dean [11] - The closure of the London center was confirmed as part of a strategic review, as it was the only unprofitable center [10][17] Q&A Session Summary Question: Can you elaborate on the cost-cutting measures taken by line and their sustainability? - Management indicated that cost controls have primarily focused on SG&A, with ongoing efforts to identify additional savings [22][23] Question: What is the uptake of the standalone skin tightening service and plans for expansion? - Management noted that while demand for skin tightening is evident, many clients require additional procedures, leading to the introduction of skin excisions [25][26] Question: What happened regarding the timing issue in Q3? - Management explained that while leads and consultations remained strong, consumer hesitance to purchase impacted revenue [31][32] Question: How will marketing strategies shift to target the GLP-1 user segment? - Management confirmed that messaging will be tailored to GLP-1 users, focusing on addressing loose skin and uneven weight loss [34][36]

Financial Data and Key Metrics Changes - For Q4 2024, revenue totaled $39.2 million, a decline of 17.7% from Q4 2023, with case volume down 16.7% year-over-year [13][33] - Adjusted EBITDA was $1.9 million or 4.7% of revenue, compared to $10.1 million or 21.2% of revenue in the same quarter last year [16][38] - For the full year, revenues were $180.4 million, a decline of 7.9% from fiscal 2023, with adjusted EBITDA of $20.7 million and an adjusted EBITDA margin of 11.5% [18][39] Business Line Data and Key Metrics Changes - Same-store revenue declined 22.6% year-over-year in Q4 2024, reflecting challenges in the aesthetics market [13][33] - The average spend per procedure remained between $12,000 and $13,000, indicating a longer conversion time from leads to cases, increasing from approximately 45 days to closer to 60 days in the second half of 2024 [14][15] Market Data and Key Metrics Changes - The percentage of patients using financing for procedures was 50%, down from 53% in previous quarters, indicating a shift in consumer behavior [34] - The company operates in a $11 billion total addressable market in the U.S., highlighting significant growth potential despite current challenges [11] Company Strategy and Development Direction - The company aims to enhance its culture and align on a singular vision while improving its go-to-market strategy to drive consistent revenue growth [20][29] - Five key priorities include marketing to drive consumer interest, improving sales processes, introducing new services, enhancing customer experience, and leveraging technology [20][28] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging consumer backdrop affecting sales across the aesthetics space and emphasized the need for internal corrections [14][12] - The company expects Q1 2025 same-store sales performance to mirror Q4 2024 trends, with an anticipated sequential improvement as marketing spend increases [30][42] Other Important Information - The company has paused new center openings to focus on improving same-center performance and has amended its credit agreement to enhance investment flexibility [29][31] - Cash flow from operations for the year was $11.4 million, down from $24 million in fiscal 2023, with gross debt outstanding at $75.8 million [41] Q&A Session Summary Question: Can you provide more color on sequential growth expectations? - Management expects to see a similar seasonal trend with sequential improvement in same-store performance year-over-year, particularly in Q2 [51] Question: What are the liquidity improvement actions being taken? - The company drew down on its revolving credit facility to maintain marketing efforts while facing challenges in Q4 results [56] Question: How should we think about marketing spend versus customer acquisition cost (CAC)? - The elevated CAC was driven by lower case volumes and reduced lead volumes due to decreased marketing spend, but improvements in marketing strategy are expected to lower CAC in the future [62] Question: Can you elaborate on the cost savings program? - The company has executed a $3 million annual savings plan primarily through reductions in corporate headcount not aligned with the current strategy, with benefits expected to start in Q1 [67] Question: What specifics can you share about new marketing efforts? - The company is combining traditional paid search with new initiatives like online video and social marketing, focusing on a returns-based approach to optimize spending [72]